Who
Hyung Heon Kim
CEO & President
Company insider
Files Form 4 as: CEO & President, MetaVia.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 9 Jun 2022
- Last trade
- 23 Jan 2026
- Last filed
- 27 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jan 2026filed 27 Jan 2026 | MTVA MetaViaBiotechnology | SEC FORM 4 Code A | —32,000 at $0.00 | filing |
| 23 Jan 2026filed 27 Jan 2026 | MTVA MetaViaBiotechnology | SEC FORM 4 Code A | —32,000 at $0.00 | filing |
| 1 Mar 2025filed 4 Mar 2025 | MTVA MetaViaBiotechnology | SEC FORM 4 Code F | $4,0812,795 at $1.46 | filing |
| 30 Nov 2024filed 2 Dec 2024 | MTVA MetaViaBiotechnology | SEC FORM 4 Code F | $7,3112,867 at $2.55 | filing |
| 11 Aug 2024filed 13 Aug 2024 | MTVA MetaViaBiotechnology | SEC FORM 4 Code F | $41K11,467 at $3.60 | filing |
| 11 Aug 2023filed 14 Aug 2023 | MTVA MetaViaBiotechnology | SEC FORM 4 Code A | —625,064 at $0.00 | filing |
| 9 Jun 2022filed 10 Jun 2022 | MTVA MetaViaoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.